Harpoon Therapeutics
Latest round
- Series C
Last raised
- Nov 2018
Total raised
- $110M
Investors
- 9
About Harpoon Therapeutics
Based in California, US, and founded in 2015 by founder Patrick Baeuerle, Harpoon Therapeutics, Inc. operates as a biopharmaceutical company providing clinical-stage immuno-oncology for cancer and other diseases., Inc. agreed to acquire Harpoon Therapeutics, Inc. from MPM BioImpact, Arix Bioscience, New Leaf Venture Partners, and many more for USD 680 million at USD 23 per share. Harpoon Therapeutics, Inc. developed immunotherapies using T-cell recruiting antibodies called TriTAC (tri-specific t-cell activating construct), designed to fight solid tumors and hematologic malignancies to treat patients with cancer and other rare diseases. The company offers ProTriTAC platform, which is a prodrug concept, supports to create a therapeutic T cell engager that remains inactive until it reaches the tumor.
Who invested in Harpoon Therapeutics
9 investors across 3 rounds
See all investors in Harpoon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Harpoon Therapeutics
Who invested in Harpoon Therapeutics?
Harpoon Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Harpoon Therapeutics raised?
Harpoon Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Harpoon Therapeutics last raise money?
Harpoon Therapeutics's most recent round on record is a Series C, in Nov 2018.
What does Harpoon Therapeutics do?
Based in California, US, and founded in 2015 by founder Patrick Baeuerle, Harpoon Therapeutics, Inc.
Where is Harpoon Therapeutics headquartered?
Harpoon Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Harpoon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Harpoon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Harpoon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.